CA2246802A1 - Antigene combine a un cytomegalovirus humain et son utilisation - Google Patents

Antigene combine a un cytomegalovirus humain et son utilisation

Info

Publication number
CA2246802A1
CA2246802A1 CA002246802A CA2246802A CA2246802A1 CA 2246802 A1 CA2246802 A1 CA 2246802A1 CA 002246802 A CA002246802 A CA 002246802A CA 2246802 A CA2246802 A CA 2246802A CA 2246802 A1 CA2246802 A1 CA 2246802A1
Authority
CA
Canada
Prior art keywords
human cytomegalovirus
hcmv
combined antigen
specific antibodies
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002246802A
Other languages
English (en)
Other versions
CA2246802C (fr
Inventor
Catharina Anna Bruggeman
Cornelis Vink
Frans Stals
Albert Ramon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mubio Products BV
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/605,541 external-priority patent/US5800981A/en
Application filed by Individual filed Critical Individual
Publication of CA2246802A1 publication Critical patent/CA2246802A1/fr
Application granted granted Critical
Publication of CA2246802C publication Critical patent/CA2246802C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16111—Cytomegalovirus, e.g. human herpesvirus 5
    • C12N2710/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CA002246802A 1996-02-22 1997-02-20 Antigene combine a un cytomegalovirus humain et son utilisation Expired - Fee Related CA2246802C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/605,541 US5800981A (en) 1996-02-22 1996-02-22 Human cytomegalovirus antigen and its use
US08/605,541 1996-02-22
PCT/EP1997/000865 WO1997031117A2 (fr) 1996-02-22 1997-02-20 Antigene combine a un cytomegalovirus humain et son utilisation

Publications (2)

Publication Number Publication Date
CA2246802A1 true CA2246802A1 (fr) 1997-08-28
CA2246802C CA2246802C (fr) 2006-12-05

Family

ID=37560872

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002246802A Expired - Fee Related CA2246802C (fr) 1996-02-22 1997-02-20 Antigene combine a un cytomegalovirus humain et son utilisation

Country Status (1)

Country Link
CA (1) CA2246802C (fr)

Also Published As

Publication number Publication date
CA2246802C (fr) 2006-12-05

Similar Documents

Publication Publication Date Title
WO1997031117A3 (fr) Antigene combine a un cytomegalovirus humain et son utilisation
EP0832105A4 (fr) Peptides immunogenes de l'antigene specifique de la prostate
AU1866895A (en) Human monoclonal antibodies to herpes simplex virus and methods therefor
AU6017194A (en) Modified hydrolyzed vegetable protein microspheres and methods for preparation and use thereof
ZW17893A1 (en) Modified hydrolyzed vegetable protein microspheres and methods for preparation and use thereof.
AUPN999096A0 (en) Peptides, antibodies, vaccines & uses thereof
IL109445A0 (en) Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof
WO1995016040A3 (fr) Titrage par immunofluorescence concernant la detection d'anticorps et utilisant des antigenes recombines sous forme non soluble
EP0683675A4 (fr) Anticorps monoclonaux humains contre le cytomegalovirus.
AU2133292A (en) Hcmv-specific peptides, agents therefor and the use thereof
AU2594195A (en) Detection of viral antigens coded by reverse-reading frames
CA2246802A1 (fr) Antigene combine a un cytomegalovirus humain et son utilisation
CA2270408A1 (fr) Anticorps monoclonal contre l'epitope ypyvpdya, son procede de production et son utilisation
AU1521997A (en) Screening tests for lytic cycle antigens and antibodies to kaposi's sarcoma-associated herpesvirus
CA2080408A1 (fr) Norme artificielle et serums de controle, methodes de preparation et utilisation
AU1785597A (en) Immediate early HSV-2 viral protein ICP27 as vaccine
AU635124B2 (en) Synthetic peptides specific for the detection of antibodies to HCV, diagnosis of HCV infection and prevention thereof as vaccines
AU7585998A (en) Controlling immune response to specific antigens
AU3829189A (en) Detecting antigens or antibodies
GB2279076B (en) Antibodies to fungal antigens
AU6777594A (en) Human monoclonal antibodies to human cytomegalovirus, and methods therefor
AU5157396A (en) Antibody to the syncytiotrophoblast antigen r80k and use the reof
AU646275C (en) Synthetic peptides specific for the detection of antibodies to HCV, diagnosis of HCV infection and prevention thereof as vaccines
AU5520796A (en) Peptide-based vaccine against papillomavirus infection
AP9300556A0 (en) Peptides,analogues and mixtures thereof for detecting and eliciting antibodies to the e1 and e2 protein of rubella virus

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed